Carcinoma paratiroideo · línea 1 · Ninguno
Vista determinista de la entidad fuente YAML. La autoridad clínica sigue con los ID de fuente citados y estado de firma del revisor.
Registro de base de conocimiento para la auditoría. Contenido clínico provisional: esto no es una prescripción. Un oncólogo debe verificar fuentes originales, aplicabilidad y estado de revisión.
Fuente YAML: registro completo
| Línea de tratamiento | 1 |
|---|---|
| Track | local_therapy |
| Régimen vinculado | None |
| ID | IND-PARATHYROID-CARCINOMA-1L-RESECTION |
|---|---|
| Tipo | Indicación |
| Situación | de la Convención, revisados 2026-07-11 |
| Enfermedades | DIS-PARATHYROID-CARCINOMA |
| Fuentes | SRC-NCCN-NET-2025 SRC-NCCN-THYROID-2025 |
Notas
STUB — coverage-enabling local-therapy indication for DIS-PARATHYROID-CARCINOMA. Requires endocrine-surgery / endocrine- oncology co-lead signoff before clinical publication (CHARTER §6.1 — dev-mode-exempted, safe to merge as draft content). No systemic or adjuvant drug regimen is indicated for localized, completely resected disease — surgery alone is standard of care; `recommended_regimen` is intentionally left unset (surgery-only local_therapy track, mirroring IND-MENINGIOMA-1L-RESECTION-RT). This Indication deliberately does NOT use the `phases:` / `surgery_id` mechanism (as IND-MENINGIOMA-1L-RESECTION-RT does via SUR-MENINGIOMA-RESECTION) because no Surgery entity for the en-bloc parathyroidectomy procedure has been authored yet — a follow-up authoring pass should add a Surgery/Procedure entity (proposed id SUR-PARATHYROID-EN-BLOC-RESECTION under knowledge_base/hosted/content/procedures/) and wire it via `phases` for full parity with the Meningioma pattern. The full procedure (en- bloc resection of the parathyroid tumor + ipsilateral thyroid lobe + central lymph nodes, no capsule violation) is described here in prose (rationale / do_not_do) in the interim.
Utilizado por
Algoritmos
ALGO-PARATHYROID-CARCINOMA-1L- ALGO-PARATHYROID-CARCINOMA-1L
Enfermedad
DIS-PARATHYROID-CARCINOMA- Carcinoma paratiroideo
Indicación
IND-PARATHYROID-CARCINOMA-2L-CINACALCET- IND-PARATHYROID-CARCINOMA-2L-CINACALCET